Regenerative Medicine Market by Type, Application - Global Forecast 2025-2030- Product Image

Sale

Regenerative Medicine Market by Type, Application - Global Forecast 2025-2030

Report
181 Pages
October 2024
Region: Global
360iResearch™
ID: 4857893

UP TO €665EUR$697USD£554GBP OFF until Dec 31^st 2024

The Regenerative Medicine Market grew from USD 23.02 billion in 2023 to USD 28.35 billion in 2024. It is expected to continue growing at a CAGR of 23.76%, reaching USD 102.40 billion by 2030.

Regenerative medicine is a transformative field focusing on replacing, engineering, or regenerating human cells, tissues, or organs to restore or establish normal function. It combines tissue engineering, cellular therapies, and biomaterials to target complex diseases and injuries, presenting vast therapeutic possibilities. The necessity for regenerative medicine stems from the global need to address chronic diseases, degenerative conditions, and organ shortage, providing sustainable and long-term solutions. Its applications span across cardiology, orthopedics, neurology, and oncology, among others, demonstrating significant potential in aging populations with increasing healthcare demands. Key end-use sectors include hospitals, academic research centers, and biotechnology firms. Market growth is propelled by advancements in stem cell research, gene editing technologies, and increased funding from public and private sectors. The accelerated innovation in 3D bioprinting and the advent of personalized medicine approaches offer substantial opportunities. However, the market faces limitations due to stringent regulatory frameworks, ethical concerns, high research and development costs, and infrastructural inadequacies in emerging economies. Challenges such as the integration of regenerative therapies into standard clinical practice, patient acceptance, and insurance coverage are also prevalent. Nonetheless, opportunities lie in leveraging CRISPR technology for precise gene editing and utilizing AI in drug regeneration processes to streamline R&D. Collaborative ventures between biotech companies, universities, and healthcare agencies could foster advancements and reduce barriers to market entry. The market is dynamic, characterized by rapid scientific developments and interdisciplinary collaborations. Companies focusing on scalable manufacturing techniques, cost-effective production, and strategic partnerships in emerging markets can potentially accelerate growth. Innovation can be driven in areas such as scaffold development for tissue engineering, enhancements in biomaterial properties, and the improvement of cell therapy efficacy and safety, presenting lucrative pathways for research and economic expansion.

Understanding Market Dynamics in the Regenerative Medicine Market

The Regenerative Medicine Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing adoption of stem cell technologies, gene therapies, and tissue engineering
- Rising government investments in regenerative medicine research
- Product approval coupled with increasing R&D activities by private players
Market Restraints
- High cost and regulatory issues pertaining to stem cell and regenerative medicine
Market Opportunities
- Technological advancements in regenerative medicine biologics
- Growing demand for organ transplantation and bone grafting
Market Challenges
- Ethical issues related to the use of embryonic stem cells in R&D

Exploring Porter’s Five Forces for the Regenerative Medicine Market

Porter’s Five Forces framework further strengthens the insights of the Regenerative Medicine Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Regenerative Medicine Market

External macro-environmental factors deeply influence the performance of the Regenerative Medicine Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Regenerative Medicine Market

The Regenerative Medicine Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Regenerative Medicine Market

The Regenerative Medicine Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Regenerative Medicine Market

The Regenerative Medicine Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Regenerative Medicine Market, highlighting leading vendors and their innovative profiles. These include 4D Molecular Therapeutics, Inc., Allergan PLC, Amgen Inc., Astellas Pharma Inc., Athersys, Inc., Bayer AG, CMIC HOLDINGS Co., LTD., Editas Medicine, Inc., FUJIFILM Cellular Dynamics, Inc., Gilead Sciences, Inc., Integra LifeSciences Holdings Corporation, JCR Pharmaceuticals Co., Ltd., Medtronic PLC, Mimedx Group, Novartis AG, Organogenesis Inc., Osiris Therapeutics, Inc. by Smith & Nephew PLC, REPROCELL Inc., SanBio Company Limited, Sartorius AG, Sumitomo Pharma Co., Ltd., Sysmex Corporation, Takeda Pharmaceutical Co. Ltd., Tenaya Therapeutics, Inc., Vericel Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings Inc..

Market Segmentation & Coverage

This research report categorizes the Regenerative Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Cell-Based Immunotherapy & Cell Therapy Products
  - Allogeneic Products
  - Autologous Products
- Gene Therapy Products
- Small Molecule & Biologic
- Tissue-Engineered Products
Application
- Cardiovascular
- Diabetes
- Musculoskeletal Disorders
- Ocular Disorders
- Oncology
- Wound Care

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing adoption of stem cell technologies, gene therapies, and tissue engineering
5.1.1.2. Rising government investments in regenerative medicine research
5.1.1.3. Product approval coupled with increasing R&D activities by private players
5.1.2. Restraints
5.1.2.1. High cost and regulatory issues pertaining to stem cell and regenerative medicine
5.1.3. Opportunities
5.1.3.1. Technological advancements in regenerative medicine biologics
5.1.3.2. Growing demand for organ transplantation and bone grafting
5.1.4. Challenges
5.1.4.1. Ethical issues related to the use of embryonic stem cells in R&D
5.2. Market Segmentation Analysis
5.2.1. Type: Significant applications of cell-based immunotherapies and cell therapy products in personalized treatment
5.2.2. Application: Growing significance of regenerative medicines for cardiovascular diseases
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Regenerative Medicine Market, by Type

6.1. Introduction
6.2. Cell-Based Immunotherapy & Cell Therapy Products
6.3. Gene Therapy Products
6.4. Small Molecule & Biologic
6.5. Tissue-Engineered Products

7. Regenerative Medicine Market, by Application

7.1. Introduction
7.2. Cardiovascular
7.3. Diabetes
7.4. Musculoskeletal Disorders
7.5. Ocular Disorders
7.6. Oncology
7.7. Wound Care

8. Americas Regenerative Medicine Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Regenerative Medicine Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Regenerative Medicine Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. 4DMT Receives FDA Regenerative Medicine Advanced Therapy Designation for 4D-150 Genetic Medicine for Intravitreal Treatment of Wet AMD
11.3.2. AlliedCel, a Joint Venture Between Sysmex and JCR Pharmaceuticals, Has Acquired a New Pipeline to Promote the Early Social Implementation of Regenerative Medicine Products
11.3.3. Mount Sinai Launches Institute for Regenerative Medicine
11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

12.1. Key Company Profiles
12.2. Key Product Portfolio

List of Figures

FIGURE 1. REGENERATIVE MEDICINE MARKET RESEARCH PROCESS
FIGURE 2. REGENERATIVE MEDICINE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. REGENERATIVE MEDICINE MARKET DYNAMICS
FIGURE 7. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 20. REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. REGENERATIVE MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE & BIOLOGIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE & BIOLOGIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 52. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 58. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 59. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 60. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 61. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 64. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 65. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 66. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 67. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 68. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 71. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 72. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 80. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 84. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 85. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 86. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 87. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 88. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 89. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 92. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 93. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 94. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 95. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 100. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 101. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 104. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 105. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 106. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 107. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 112. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 113. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 116. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 117. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 118. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 119. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 124. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 125. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 128. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 129. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 130. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 131. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 134. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 135. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 136. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 137. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 140. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 141. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 142. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 143. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 146. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 147. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 148. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 149. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 152. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 153. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 154. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 155. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 165. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 166. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 167. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 168. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 169. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 172. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 173. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 174. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 175. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 178. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 179. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 180. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 181. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 184. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 185. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 186. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 187. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 190. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 192. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 193. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 196. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 198. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 199. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 202. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 204. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 205. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 208. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 209. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 210. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 211. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 214. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 215. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 216. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 217. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 220. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 221. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 222. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 223. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 226. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 227. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 228. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 229. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 234. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 235. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 238. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 239. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 240. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 241. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 244. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 246. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 250. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 252. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 256. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 257. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 258. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 259. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 262. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 263. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 264. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 265. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 268. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 269. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 270. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 271. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 274. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 275. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 276. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 277. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 286. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
TABLE 288. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 290. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 291. REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 292. REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Regenerative Medicine market, which are profiled in this report, include:

4D Molecular Therapeutics, Inc.
Allergan PLC
Amgen Inc.
Astellas Pharma Inc.
Athersys, Inc.
Bayer AG
CMIC HOLDINGS Co., LTD.
Editas Medicine, Inc.
FUJIFILM Cellular Dynamics, Inc.
Gilead Sciences, Inc.
Integra LifeSciences Holdings Corporation
JCR Pharmaceuticals Co., Ltd.
Medtronic PLC
Mimedx Group
Novartis AG
Organogenesis Inc.
Osiris Therapeutics, Inc. by Smith & Nephew PLC
REPROCELL Inc.
SanBio Company Limited
Sartorius AG
Sumitomo Pharma Co., Ltd.
Sysmex Corporation
Takeda Pharmaceutical Co. Ltd.
Tenaya Therapeutics, Inc.
Vericel Corporation
Wright Medical Group N.V.
Zimmer Biomet Holdings Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	181
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 28.35 Billion
Forecasted Market Value ( USD ) by 2030	$ 102.4 Billion
Compound Annual Growth Rate	23.7%
Regions Covered	Global
No. of Companies Mentioned	28

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3385EUR$3,545USD£2,818GBP €3761EUR$3,939USD£3,131GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€5989EUR$6,272USD£4,986GBP €6655EUR$6,969USD£5,539GBP

Understanding Market Dynamics in the Regenerative Medicine Market

Exploring Porter’s Five Forces for the Regenerative Medicine Market

Applying PESTLE Analysis to the Regenerative Medicine Market

Analyzing Market Share in the Regenerative Medicine Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Regenerative Medicine Market

Strategic Recommendations for Success in the Regenerative Medicine Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Additional Product Information:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application (Musculoskeletal, Cancer, Dermatology, Wound care, Cardiovascular Diseases, Eye Disorders) - Forecast to 2028

Global Regenerative Medicine Market Size, Share & Trends Analysis Report by Product (Primary Cell-based Therapeutics, Stem Cell & Progenitor Cell-based Therapeutics), Therapeutic Category (Dermatology, Musculoskeletal), Region, and Segment Forecasts, 2024-2030

Regenerative Medicine Market: Trends, Forecast and Competitive Analysis

Regenerative Medicine Market Report by Type, Application, End User, and Region 2024-2032

Global Artificial Intelligence in Regenerative Medicine Market by Technology (Computer Vision, Context-Aware Computing, Machine Learning), Offering (Hardware, Services, Software), Application, End-User - Forecast 2024-2030